GIRONA BIOMEDICAL RESEARCH INSTITUTE DR. JOSEP TRUETA (IDIBGI) opens the selection process to
cover one job position to be part of the RBD Hetrodimer research project recombinant protein vaccine
against SARSCoV2, with official code 101046118 :” A phase III, open label, single arm, multi-center, trial
to assess the immunogenicity and safety of an additional dose vaccination with a recombinant protein
rbd fusion heterodimer candidate (phh-1v) against sars-cov- 2, in adults with pre-existing
immunosupressive conditions vaccinated against covid-19” , , funded by the European Commission, in
the following professional category:
AACC Coordinator